Thus, we designed and successfully applied AAV mediated muscle‐specific muscle creatine kinase (MCK) promoter‐driven NLS‐PGC1α4 in GAS muscle and alleviated aging‐associated sarcopenia and metabolic disorders, including adiposity, insulin resistance, and fatty liver. Here, CKM is linked to metabolic disease.